Research Rheum

Ethics Forum: The Ethical Pitfalls of Clinical Trials

Robert H. Shmerling, MD | April 6, 2012

Your patient is deciding whether to enroll in a clinical trial at your institution and wants your advice about whether to participate.

First ARHP ‘Best of the Meeting’ Highlights Sleep Research, Osteoporosis Screening, More

Kathleen Louden | March 8, 2012

“The line between ACR and ARHP sessions has totally blurred,” said Donah Zack Crawford, MA, during the presentation, “Highlights from the 2011 ARHP Sessions,” here at the 2011 ACR/ARHP Annual Scientific Meeting held in Chicago in November 2011.

A Journey Begins with the First Step

David I. Daikh, MD, PhD | March 8, 2012

The ACR Research and Education Foundation (REF) has launched the Action Alliance network, a program that calls on rheumatologists, investigators, and health professionals to join the REF in asking patients and families to be a part of the conversation. The Action Alliance consists of two programs working together: From the Field Speakers Bureau and Patients and Families for Progress.

Magnify Rheumatology’s Legislative Impact this Month

Staff | March 8, 2012

Members of the ACR’s Executive, Government Affairs, and RheumPAC Committees, along with the Affiliate Society Council, attended 75 meetings with legislators and their staff. These meetings are critical to advancing awareness of rheumatology and the issues affecting your profession and patients.

Where Will Kinase Inhibitors Fit into the RA Treatment Mix?

Vanessa Caceres | March 8, 2012

Presenters at “Looking Ahead to Kinase Inhibition in Rheumatoid Arthritis,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting, delved into some of the big questions that rheumatology faces with kinase inhibitor use.

Link between Autoimmunity and Environmental Exposure Needs Further Research

Vanessa Caceres | March 8, 2012

Rheumatology needs further cost-effective and validated methods to track the connection between environmental exposure and autoimmune diseases, including research on phenotypes, genotypes, the synergy between multiple infectious and noninfectious exposures, the timing of exposure, and the mechanisms involved, according to presenters of “Impact of Environmental Health on Autoimmunity,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting held in Chicago in November 2011.

Scientists Pinpoint Three HLA Proteins Linked to Seropositive Rheumatoid Arthritis

Carrie Printz | February 28, 2012

Researchers have identified five amino acids in three HLA proteins that explain most of the association between major histocompatibility complex (MHC) and seropositive rheumatoid arthritis (RA).

Challenges and Rewards of a Physician Executive Career

Catherine Kolonko | February 3, 2012

The job of a physician executive offers a different set of challenges for rheumatologists familiar with research and patient care.

Trailblazers in Rheumatology

Staff | February 3, 2012

Since the beginning of their medical careers, Rodanthi C. Kitridou, MD, and Bevra H. Hahn, MD, have seen a huge shift in the demographics of the field.

ACR Volunteers Attend Leadership Development Conference

Staff | February 3, 2012

Last month, volunteers from the ACR, ARHP, and REF met in Atlanta for the Annual Leadership Development Conference. This year’s conference focused on media relations and social media in a healthcare environment. The goal of this year’s conference was to educate the volunteers on how to successfully use the different types of media outreach. The topics were timely, what with the launch of the ACR’s first public relations campaign, Simple Tasks, and a successful social media session held at the 2011 ACR/ARHP Annual Scientific Meeting.